HK Stocks Close: HSI Up 1.05%, Gold, Pharma & Property Lead Gains, Guotai Junan International Surges 37% on Trading Resumption
Claire Weston
The Hang Seng Index rose 1.05% to 25,937, as a surprise US non-farm payroll contraction cooled rate-hike bets and drove capital into gold, pharma, and property plays — turnover hit HK$240.3 billion.
Why did weak US jobs data lift all of Hong Kong?
US non-farm payrolls shrank by 23,000 in July; prior two months revised down a cumulative 103,000 — a clear signal the labour market is cooling.
This means → markets now price in even less chance of further Fed tightening, giving risk assets room to breathe.
The Hang Seng Tech Index led gains at +1.26% (4,919); the H-share Index rose 1.06% (8,621).
What drove the gold-stock surge?
Lao Pu Gold (06181) topped blue chips, closing up 12.39% at HK$395.6; Chow Tai Fook gained 6.63%; Zijin Gold International rose 5.03%.
Spot gold rallied over 7% last week — its best weekly gain this year — fuelled by soft payrolls and China's central bank buying 19.91 tonnes in July, the 21st consecutive month of reserve accumulation.
In plain terms = two forces pushed gold simultaneously: US data weakened rate expectations, while the PBOC kept buying physical metal. Morgan Stanley says gold is stabilising in Q3; Lao Pu stores saw queues return in early August.
What powered the pharma rally?
AI drug discovery and CRO names led: Hansoh Pharma +4.92%, Biocytogen-B +11.08%, Jitai Tech-P +7.91%, XtalPi +7.68%.
WuXi AppTec (02359) won a preliminary injunction from a US federal court — the DoD cannot enforce its 1260H listing during litigation — while the company posted record half-year results and raised full-year guidance.
This means → legal uncertainty is effectively frozen for now; combined with a beat-and-raise, it created a double catalyst.
What signal does Beijing's housing policy send?
Non-Beijing-resident purchase threshold cut to 1 year of social security; provident-fund loan cap raised to RMB 3.4 million — Country Garden +8.99%, Shimao +4.41%, Sunac +4.31%.
Guojin Securities notes Beijing's market already shows stabilising demand, shrinking supply, and first-home-buyer dominance; the new policy's impact may match or exceed Shanghai's "Seven Measures" from February.
In plain terms = regulators are lowering the bar step by step, aiming to pull in buyers who are "almost qualified" and anchor transaction volume and price expectations.
What explains the single-stock movers?
Guotai Junan International (01788) surged 36.78% on resumption — Guotai Haitong Financial Holdings plans a HK$3/share scheme of arrangement to take the company private; the close at HK$2.845 still implies upside to the offer.
Peijia Medical-B rose 19.3%: H1 revenue grew 17.4–23.1% YoY on dual-track expansion in transcatheter valves and neuro-intervention.
Maoyan Entertainment gained 10.31%: Shen Teng's new film *Welcome to Dragon Restaurant* has crossed RMB 100 million in pre-sales; the 2026 summer box office already tops RMB 8.5 billion.
What should investors watch next?
Innolight (03308) fell 6.94% against the tape — US peer Applied Optoelectronics (AAOI) disclosed aggressive expansion plans, targeting a tenfold capacity increase by next year, raising competitive-landscape concerns.
Huatai Securities argues the current HK rally stems largely from cross-market rebalancing during AI-hardware de-leveraging, with strong fund-flow-driven characteristics.
This means → whether optical, memory, and chip names can stabilise is the key tell for the next phase — if they cannot, capital will keep rotating into low-vol dividends and consumer staples.
Content is for reference only, not financial advice.